Samples were extracted in OGT buffer (44.4 mM
n-Octyl β-D glucopyranoside, 1% Triton X-100, 100 mM NaCl, 1 mM MgCl
2, 5 mM EDTA, 10 mM imidazole) containing 1 mM sodium vanadate, 0.2 mM H
2O
2, and a protease inhibitor cocktail (Sigma, St. Louis, MO). Protein concentrations were determined with an assay (BCA assay; Pierce, Rockford, IL). Proteins were separated on Tris-glycine gels (Novex, San Diego, CA), electrophoretically transferred to membrane (Immobilon-P; Millipore Corp., Bedford, MA), and immunoblotted as described previously.
16 For detection, reagent (ECL; Amersham Life Sciences, Arlington Heights, IL) was used. Immunoblots were scanned, and densitometry analysis was performed (1D software; Eastman Kodak, Rochester, NY). Values were normalized (± SEM) to those of day (D) 3 or D6, as indicated in the figure legends, and plotted on graphs. All gels were run under reducing conditions. Antibodies used included c-Src (Santa Cruz Biotechnology, Santa Cruz, CA; directed against a peptide in the Src C-terminus that is common to all SFK family members), phosphoSrc418 (Biosource, Camarillo, CA; the 418 site is common among SFK family members), β-actin (Sigma, St Louis, MO), α-smooth muscle actin (Sigma), β-catenin (BD Biosciences, Franklin Lakes, NJ), FAK Y397 (BD Biosciences), fibronectin (Developmental Studies Hybridoma Bank), and PCNA (Sigma). Fluorescence-conjugated phalloidin, which binds filamentous actin, was obtained from Molecular Probes (Eugene, OR).